The recently published World Health Organization (WHO) 2022 classification and the International Consensus Classification of Myeloid and Lymphoid Neoplasms (ICC-MLN) define a distinct subcategory of myeloid neoplasms as “myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions” (MLN-TK) [1, 2]. The gene discussed is MLN; the disease is lymphoid neoplasm.